Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: An exploratory randomised control study

Journal of Clinical Nursing

Volumn 25, Issue 5-6, 2016, Pages 664-671

  Fang, Ronghua ^a   Li, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Coronary heart disease; Health intervention; Kik messaging; Lipid lowering drugs; Micro letter; Short message service; Statins

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; AGED; AMBULATORY CARE; CHINA; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; REMINDER SYSTEM; TEXT MESSAGING;

ADULT; AGED; AMBULATORY CARE; CHINA; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT DISCHARGE; REMINDER SYSTEMS; TEXT MESSAGING;

EID: 84958154334     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/jocn.12988     Document Type: Article

References (30)

1. Chen YF, Madan J, Welton N, Yahaya I, Aveyard P & Bauld L (2012) Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technology Assess 16, 1-205.
2. Cheng TO (2004) The current state of cardiology in China. International Journal of Cardiology 96, 425-439.
3. Chiang-Hanisko L, Tan JY & Chiang LC (2014) Polypharmacy issues in older adults. The Journal of Nursing 61, 97-104.
4. Clearfield MB (2002) Statins: balancing benefits, efficacy and safety. Expert Opinion on Pharmacotherapy 3, 469-477.
5. Fonarow GC, French WJ, Parsons LS, Sun H & Malmgren JA (2001) Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Circulation 103, 38-44.
6. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, de Backer G, Hjemdahl P, López-Sendón J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology & ESC Committee for Practice Guidelines (CPG) (2006) Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the European Society of Cardiology. European Heart journal 27, 1341-1381.
7. Gayet JL, Paganelli F & Cohen-Solal A (2011) Update on the medical treatment of stable angina. Archives of Cardiovascular Diseases 104, 536-544.
8. He X, Liu YZ & Liu YJ (2012) Correlation between coronary heart disease and dyslipidemia. Chinese Journal of Cardiovascular Rehabilitation Medicine 21, 57-58.
9. Ho PM, Bryson CL & Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119, 3028-3035.
10. Hussein WI, Hasan K & Jaradat AA (2011) Effectiveness of mobile phone short message service on diabetes mellitus management: the SMS-DM study. Diabetes Research and Clinical Practice 94, e24-e26.
11. Kitagawa Y, Teramoto T & Daida H (2012) Adherence to preferable behavior for lipid control by high-risk dyslipidemic Japanese patients under pravastatin treatment: the APPROACH-J study. Journal of Atherosclerosis Thrombosis 19, 795-805.
12. Lauck S, Johnson JL & Ratner PA (2009) Self-care behavior and factors associated with patient outcomes following same-day discharge pereutaneous coronary intervention. European Journal of Cardiovascular Nursing 8, 190-199.
13. Li Y & Zhang XY (2010) Statins pleiotropic application progress in cardiovascular disease. Cardiovascular Epidemiology 31, 127-130.
14. Lowry KP, Dudley TK, Oddone EZ & Bosworth HB (2005) Intentional and unintentional nonadherence to antihypertensive medication. The Annals of Pharmacotherapy 39, 1198-1203.
15. Magometschnigg D & Rothmayer G (2011) Hypertension short message service. Wiener MedizinischeWochenschrift 161, 353-358.
16. Morisky DE, Green LW & Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 24, 67-74.
17. Okrainec K, Banerjee DK & Eisenberg MJ (2004) Coronary artery disease in the developing world. American Heart Journal 148, 7-15.
18. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG & Wedel H (2004) Randomised trial of cholesterol lowering in 4444 patients with coronary heart Scandinavian Simvastatin Survival (4S). 1994. Atherosclerosis Supplements 5, 81-87.
19. Phan K, Gomez YH, Elbaz L & Daskalopoulou SS (2014) Statin treatment non-adherence and discontinuation: clinical implications and potential solutions. Current Pharmaceutical Design 20, 6314-6324.
20. Rajpura J & Nayak R (2014) Medication adherence in a sample of elderly suffering from hypertension: Evaluating the influence of illness perceptions, treatment beliefs, and illness burden. Journal of Managed Care Pharmacy 20, 58-65.
21. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR & Braunwald E (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, Cholesterol and Recurrent Events Trial investigators. The New England Journal of Medicine 335, 1001-1009.
22. Schedlbauer A, Davies P & Fahey T (2010) Interventions to improve adherence to lipid lowering medication. The Cochrane Database System Reviews Issue 3, Art No.: CD004371.
23. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA & Taubert KA (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113, 2363-2372.
24. Stephens J & Allen J (2013) Mobile phone interventions to increase physical activity and reduce weight: a systematic review. The Journal of Cardiovascular Nursing 28, 320-329.
25. Stuurman Bieze AG, Hiddink EG, vanBoven JF, Vegter S, Stuurman-Bieze AG, Hiddink EG, van Boven JF & Vegter S (2013) Proactive pharmaceutical care interventions improve patients adherence to lipid-lowering medication. The Annals of Pharmacotherapy 47, 1448-1456.
26. Szilagyi PG & Adams WG (2012) Text messaging: a new tool for improving preventive services. The Journal of the American Medical Association 307, 1748-1749.
27. RL Gao (2007) The Lipid Research Clinics Coronary Prevention Trial results, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. The Journal of the American Medical Association 251, 351-364.
28. The Long Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The New England Journal of Medicine 339, 1349-1357.
29. Thomas RJ, King M, Lui K, Oldridge N, Piña IL & Spertus J (2007) AACVPR/ACC/performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Journal of Cardiopulmonary Rehabilitation and Prevention 27, 260-290.
30. Wong MC, Liu J, Zhou S, Li S, Su X, Wang HH, Chung RY, Yip BH, Wong SY & Lau JT (2014) The association between multimorbidity and poor adherence with cardiovascular medications. International of Journal Cardiology 177, 477-482.